Cargando…
FDA limits authorised use of Janssen COVID-19 vaccine
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099335/ http://dx.doi.org/10.1007/s40278-022-14892-2 |
Ejemplares similares
-
Factors affecting COVID-19 vaccine acceptability in the US
Publicado: (2020) -
No evidence of adverse neurological outcomes from COVID-19 vaccines
Publicado: (2022) -
Thrombocytopenic purpura with AstraZeneca but not Pfizer-BioNTech COVID-19 vaccine
Publicado: (2021) -
Pfizer COVID-19 vaccine recommended for pregnant women in Australia and New Zealand
Publicado: (2021) -
UK's NICE issues guideline on diagnosing rare COVID-19 vaccination-related blood clots
Publicado: (2021)